USP28-IN-3
USP28-IN-3 is a USP28 inhibitor (IC50=0.1 μM) with high selectivity over USP2, USP7, USP8, USP9x, UCHL3 and UCHL5. USP28-IN-3 shows cytotoxicity against cancer cells, down-regulates the cellular level of c-Myc through ubiquitin-proteasome system. USP28-IN-3 also decreases the ankyrase-1/2 level in vitro. USP28-IN-3 enhance the sensitivity of colorectal cancer cells to Regorafenib (HY-10331) [1].
Product Specifications
CAS Number
[2931509-14-5]
UNSPSC
12352005
Target
Deubiquitinase
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/usp28-in-3.html
Purity
98.26
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CS(=O)(C1=CC=C(C(Cl)=C1)C(NC2=CC=C(C(C3=CC4=C(CNCC4)C=C3)=C2)Cl)=O)=O
Molecular Formula
C23H20Cl2N2O3S
Molecular Weight
475.39
References & Citations
[1]Zhou D, et al. Structure-based discovery of potent USP28 inhibitors derived from Vismodegib. Eur J Med Chem. 2023 Jun 5;254:115369.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
![Human Monoclonal IL-6 Antibody (clazakizumab) [mFluor Violet 450 SE]](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
Human Monoclonal IL-6 Antibody (clazakizumab) [mFluor Violet 450 SE]
